I. INTRODUCTION
Silver and several silver compounds have long been used as antimicrobial agents ͑Klasen, 2000a, b; De Gracia, 2001; Modak et al., 1983; Nomiya et al., 1995 Nomiya et al., , 1997 Nomiya and Yokoyama, 2002͒ . Particularly, silver͑I͒-sulfadiazine has been used clinically as an antimicrobial and antifungical agent. It is an insoluble polymeric compound that releases Ag͑I͒ ions slowly, and is applied topically as a cream to prevent bacterial infections in cases of severe burns.
Sodium cyclamate ͑sodium cyclohexane-sulfamate, NaC 6 H 12 NO 3 S, see Figure 1͒ is a compound used as a commercial sweetener. In general, sweeteners have functional groups like carbonyl, carboxylate, amino, and sulfamate, which allow them to be used as ligands in coordination and bioinorganic chemistry. Cyclamate complexes, in general, exhibit low toxicity in humans and could be the basis of pharmaceutical products.
Considering that silver͑I͒ compounds have antibacterial properties and that sodium cyclamate has low toxicity and low manufacture costs, a silver͑I͒-cyclamate complex was obtained in our laboratories. In fact, the compound reported in this paper showed a potent antimicobacterial activity against species of mycobacterium, including mycobacterium tuberculosis, which is responsible for tuberculosis infections. The other species tested were mycobacterium avium, mycobacterium intracellulare, mycobacterium malmoense, and mycobacterium kansasii ͑data not reported͒.
The aim of our work is to characterize the silver͑I͒-cyclamate complex using a collection of techniques including X-ray powder diffraction. In this contribution, the X-ray powder diffraction data for silver͑I͒ cyclamate, Ag͑C 6 H 12 NO 3 S͒, are reported.
II. EXPERIMENTAL
Sodium cyclamate ͑99.0% of purity͒ was purchased from Nutrasweet Kelco Company. Silver͑I͒ nitrate is an Acros Organics Company product, of 99.8% purity. The compounds were used without further purification.
To synthesize the Ag͑C 6 H 12 NO 3 S͒ complex, an aqueous solution of AgNO 3 ͑0.340 g, 2.0 mmol͒ was added under stirring to a solution containing 0.402 g ͑2.0 mmol͒ of sodium cyclamate. White crystalline powders of the complex were obtained. The compound was washed with 200 mL of water and dried over P 4 O 10 under vacuum.
Elemental analysis of carbon, hydrogen, nitrogen, and sulfur was performed using a CHNS-O EA1110 Analyzer, CE Instruments, and high purity cysteine was used as a reference substance. The silver content was determined by atomic absorption spectroscopy using an A Analyst 300 Perkin Elmer spectrometer. The infrared spectrum was recorded on a Spectrum 2000 FT-IR Perkin Elmer spectrophotometer from KBr pellets. Measured concentrations ͑wt.%͒ for C 6 H 12 AgO 3 NS were determined to be C, 25.5; H, 4.35; N, 5.04; S, 11.2; and Ag, 38.8%, while the calculated concentrations are C, 25.2; H, 4.23; N, 4.89; S, 11.2; and Ag, 37.7%.
III. INSTRUMENTATION
X-ray diffraction data were obtained using synchrotron radiation in the D10B-XPD line of the Laboratorio Nacional de Luz Sincrotron ͑LNLS͒ in Brazil. The experimental setup consisted of a Si ͑111͒ double-crystal monochromator with the first crystal refrigerated and the second sagitally curved. A scintillation detector was used. The monochromator was adjusted to select the energy E = 8.4995 keV ͑ = 1.45864 Å͒, that is the energy of maximum intensity at the LNLS in Brazil. −2 geometry was used; a Y 2 O 3 sample was used as reference material to check for the wavelength and instrumental broadening. The sample was deposited in a flat sample holder of 10ϫ 12 mm 2 . Data were collected from 9 to 50°2, with step scan of 0.005°2. The software XFit ͑Coelho and Cheary, 1997͒ was used to fit 46 peaks that were used for the indexing with the Crysfire suite ͑Shirley, 2002͒. The GSAS suite program ͑Larson and von Dreele, 2001͒ was used for the Le Bail fit. The Thompson-Cox-Hastings pseudo-Voigt function was used as the profile function. During the refinements, only the profile parameters that vary with sec and tg were refined.
IV. RESULTS AND DISCUSSION
According to the elemental analysis for C, H, N, and S, the formula of the complex is The analysis of the diffraction data with Crysfire and Chekcell resulted in two solutions, each one with three possible space groups ͑Table I͒. All solutions were used for the Le Bail fit and the agreement factors for all six fits are in Table II . Lower 2 values were obtained for the first solution with the space group C2/c, and the unit cell parameters for this case are a = 31.851 95͑19͒ Å, b = 6.250 87͑6͒ Å, c = 8.459 70͑6͒ Å, and ␤ = 95.765͑0͒°. The relative intensities for the best fit are in Table III . The powder diffraction data, after the indexing, are shown in Table III . The results of the profile fit are shown in Figure 2 .
Density measurements ͑pycnometric determination under helium, after a careful evacuation͒ were used to determine an experimental density of 2.375 g / cm 3 . This experi- mental value, combined with the molar mass of the complex, allowed for the calculation of the number of formula weight contained in a cell, equal to 8 ͑Z =8͒.
V. CONCLUSION
A new silver͑I͒-cyclamate complex that presents a potent antimicobacterial activity against species of mycobacterium, including mycobacterium tuberculosis, has been prepared and characterized using X-ray powder diffraction. The formula of the complex, determined by elemental analysis, is Ag͑C 6 H 12 NO 3 S͒. At room temperature the silver͑I͒-cyclamate complex has monoclinic symmetry with unit cell parameters a = 31.858 52͑16͒ Å, b = 6.2526͑6͒ Å, c = 8.461 65͑7͒ Å, and ␤ = 95.7651͑5͒°, with three space groups being possible ͑C2/c , Cc , Ca͒. Crystal structure determination is necessary for the definition of the space group. 
